Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Marijuana
What Metric Jim Cramer Watches in Every Cannabis Earnings Report
Overwhelmed by the cannabis earnings reports? Here's the metric that Jim Cramer watches.
Pot Stocks Trade Mixed Following Tilray's Fourth-Quarter Results
Tilray shares turn following the company's fourth-quarter results while other pot stocks trade mixed.
Cause for Caution? Top Executives Selling Tilray Stock
It might not be time to panic yet about Tilray, but there's likely a problem ahead.
Another Hemp Play to Consider: Charlotte's Web Holdings
Investors looking for another hemp play might consider Charlotte's Web Holdings, which deals in a range of CBD wellness products.
Why Jim Cramer Believes Canopy Could Be the Next Amazon
Jim Cramer said that he believes that Canopy Growth could be the next Amazon. Here's why he thinks that the cannabis company could be the next Amazon.
How Jim Cramer Felt About Tilray's Earnings Call
Jim Cramer says that Tilray's earnings call disappointed him. Here's why he wasn't blown away.
Kass: Tilray Is Promising but I Prefer This Other Stock in the Pot Space
Tilray will not be cash flow positive for another 2-3 years - that's not quick enough progress for me given its $7 billion dollar capitalization.
Tilray Has Rebased and Looks Poised to Rally Again - Consider Buying Strength
Let's check out the charts and indicators for this so-called pot play.
Tilray Rises Sharply on Revenue Beat
Tilray shares rose in after-hours action on strong revenue as traders shrugged off a wider-than-expected loss.
Here's How Tilray Is Doing Ahead of Monday's Earnings Release
Tilray is expected to increase its revenue by more than 50% from the previous quarter.